The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I always wondered why the SP dropped quite so low between the hearing and the judgement and I suspect this result has been know for sometime in certain circles. My guess the SP will settle back around 4p pre 18th Jan RNS level reflecting valuation of SYM having lost court case. Always someone more in the know than you is my lesson!!
I don't know the Dyson case tbh and what they were claiming, but if SYM do win their case, I would have thought it would be hard to dispute that they have suffered a financial loss as a result, as they have effectively been banned from trading in the EU given that probably over 95% of their revenues over the time period involved have been derived from D2W. To refuse any compensation claim the court would surely have to establish there has been no impact on trading performance?
I don't know about that. I could see quite a few thinking this worth a punt over next 2 weeks. Its been so bad for ages that the downside is limited but the upside if they win the EU case could be massive. A lot riding on the decision I think with a lot of deals being unlocked if they win. Not to mention the compensation if awarded which could amount to £100m+ by now (they lodged over £80m in damages 3 years ago I believe). At this price someone could make large multiple on investment in very short space of time so I think we'll see some speculation. I would buy if I wasn't already all in and underwater!!
Artji, good post. I am inclined to agree. It always seems to be just out of reach. When are some of the '100 customer led trials' going to materialise? Where is the big bread packaging deal? When is the Saudi enforcement actually going to impact on sales etc etc? I own about 0.8% of the company bought between 5 and 10 years ago. I hope CTW is right and given the strong statements made over last year or so about 'transformational' deals in the 'near term' etc (although still waiting - which makes you wonder why they need this Brennan 'the finisher' bloke!), I think they will finally lose all credibility if it doesn't shift soon. I've invested way too much time and money in this share and if nothing 'transformational' by the end of this year then it will finally be time to give up the ghost. I will be gutted as will have wasted 10 years of my life on it. I agree that its time shareholders started expressing their frustration and urgency.
Thanks Ctw and GGG. Makes sense
Does anyone know what 'constant currency' means when they are saying revenue would have been 13% higher on that basis?
Thanks DL
As I say - I'm no expert so will bow to your knowledge. In which case it is a huge shame they haven't gone one step further to remove any doubt and be able say it explicitly on the marketing.
See below link to WHO definitions of COVID-19 and SARS-COV-2.
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it
I wish they had made it clearer as I don't think the market understood this and the Sept announcement should have had a bigger impact on SP than the July one!
Hi DavidLaw
I'm no expert but my understanding is they have tested D2P on the exact virus which causes COVID-19. The initial tests by Eurofins announced on 23rd July were on a surrogate bovine form of CoronaVirus as they couldn't initially find a lab with spare samples of the SARS-COV-2 strain which effects humans. However the subsequent UNICAMP University test results announced on 14th Sept used the actual SARS-COV-2 strain of the virus. They used a bovine foetal serum as the host cell (funnily enough they don't experiment on human foetuses!). COVID-19 is technically the term of the disease in humans not the virus itself which causes it. They have established that D2P kills the virus which causes COVID-19 (SARS-COV-2) within 1 hour of contact. I agree they could have made this MUCH clearer in the announcements but if you re-read the 14th Sept RNS - that is what it is effectively saying.
…there most certainly is
We should all be clear that they are not seeking any further tests and that they have tested against the virus that causes COVID 19
Crazy fund - when did you send your enquiry? Before the announcement on Monday? That was the stock response in relation to the Eurofins testing. I suggest you resubmit in relation to the UNICAMP testing which is the independent laboratory testing they were waiting for. That is out of date as they are referring to the April RNS
...i.e. there is no more testing they need to do!
SARS-CoV-2 is the virus that causes COVID19 disease in humans. It is THE virus that the whole world is panicking about and SYM have proven that D2P kills the virus within an hour. I don't understand why this isn't going ballistic. They probably should have made the RNS clearer that this is THE VIRUS!
Can I just mediate a little and say that I agree with Sam 7 that Director bed and ISA dealings do unsettle the market in the short term simply because any Director deals tend to suggest that there is no significant deal news in the immediate pipeline. A lot of short term traders therefore come out and go elsewhere. I don't know whether ISA transfers count as inside deals but as they have to be announced I assume they are. However I also agree with Truro that I see it as very positive in the medium term because it is only worth doing a bed and ISA if you think there are significant CGT savings to be made - i.e. big gains to be had on the price at which the ISA transfer is made. I think the Directors are perfectly entitled to do this and I have done the same with this share. I see it as a medium term positive in that they are taking the opportunity to load up their ISAs when they can. It possibly means there is no substantial announcement in the immediately short term, otherwise they would probably get in trouble with the tax man, but if you believe in this just relax, hold and wait for the news as it could be big. Don't worry about a short term pull back.
Agreed. I know this company have a history of over-promising/ under-delivering but this is probably the most tangible announcement for years. They have tailored the business to the established revenues, and appear at last to be gaining traction with the potentially much bigger (in my opinion) side of the business. I would have expected some movement here. All I can think is it's a case of 'Cry Wolf' unfortunately.